Increasing maternal body mass index shows a moderate to strong dose-response relationship with increasing risks of fetal death, stillbirth, neonatal death, perinatal death, and infant death,...
A 6-year program of diet, exercise, or both helped delay the onset of diabetes in adults, and had significant mortality benefits for women 23 years later, researchers reported online in the Lancet...
Once-daily liraglutide slightly outperformed once-weekly albiglutide in a head-to-head trial in adults with poorly controlled type 2 diabetes, researchers reported in the April issue of the Lancet...
In patents with type 2 diabetes, weekly injections with exenatide controlled hemoglobin A1c levels more effectively than did daily glargine over a 3-year period, investigators reported...
WASHINGTON – A novel pharmacologic approach to the prevention of ischemic events in patients with stable coronary heart disease failed to reduce the combined risk of cardiovascular death, acute...
HYATTSVILLE, MD. – Inhaled insulin will probably become available as a treatment option again, with a Food and Drug Administration advisory panel’s recommendation to approve an orally administered...
WASHINGTON – In the large STABILITY trial, darapladib did not significantly reduce the primary endpoint of cardiovascular death, MI, or stroke in patients with stable coronary disease.
The novel...
WASHINGTON – Bariatric surgery has the greatest amount of data demonstrating its efficacy in reducing the comorbidities of obesity, as well as providing a long-term solution to the disease itself,...
Adding hemoglobin A1c level to traditional cardiovascular risk factors doesn’t improve the prediction of incident cardiovascular disease among middle-age and older adults who don’t have...
Frequent consumption of fried foods may exacerbate a genetic predisposition to obesity, according to results from a large cohort study that found a significant interaction between fried food...